Stockscreener 앱 받기
33.72
0.24%
-0.065
전일 마감가:
$33.78
열려 있는:
$33.7
하루 거래량:
515.56K
Relative Volume:
0.28
시가총액:
$5.38B
수익:
$616.29M
순이익/손실:
$447.18M
주가수익비율:
12.14
EPS:
2.7771
순현금흐름:
$-24.99M
1주 성능:
-7.97%
1개월 성능:
+0.36%
6개월 성능:
-3.11%
1년 성능:
-25.72%
1일 변동 폭
$33.23
$34.00
1주일 범위
$33.23
$36.99
52주 변동 폭
$25.28
$45.97
TG테라퓨틱스사 Stock (TGTX) Company Profile
명칭
Tg Therapeutics Inc
전화
(212) 554-4484
주소
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Compare TGTX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
33.71 | 5.52B | 616.29M | 447.18M | -24.99M | 2.7771 |
VRTX
Vertex Pharmaceuticals Inc
|
424.34 | 109.41B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
703.68 | 76.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
782.92 | 48.20B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
300.30 | 40.31B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
292.83 | 33.13B | 5.36B | 287.73M | 924.18M | 2.5229 |
TG테라퓨틱스사 Stock (TGTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-06 | 재개 | H.C. Wainwright | Buy |
| 2025-07-10 | 재개 | Goldman | Neutral |
| 2024-10-29 | 개시 | TD Cowen | Buy |
| 2023-08-02 | 업그레이드 | Goldman | Sell → Neutral |
| 2023-06-26 | 재개 | Jefferies | Buy |
| 2022-05-20 | 개시 | BofA Securities | Underperform |
| 2022-02-23 | 재확인 | B. Riley Securities | Buy |
| 2021-11-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-04-20 | 개시 | Goldman | Neutral |
| 2021-04-19 | 재확인 | H.C. Wainwright | Buy |
| 2020-09-01 | 개시 | JP Morgan | Overweight |
| 2020-08-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-05 | 개시 | Evercore ISI | Outperform |
| 2020-01-17 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-27 | 재개 | B. Riley FBR | Buy |
| 2019-02-06 | 재개 | Jefferies | Buy |
| 2018-09-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | 재개 | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | 재개 | H.C. Wainwright | Buy |
| 2017-04-25 | 개시 | Jefferies | Buy |
| 2017-03-06 | 재확인 | FBR & Co. | Outperform |
| 2016-10-06 | 재개 | Brean Capital | Buy |
| 2016-05-27 | 개시 | SunTrust | Buy |
| 2015-12-01 | 개시 | FBR Capital | Outperform |
| 2015-09-09 | 개시 | Raymond James | Strong Buy |
| 2015-08-12 | 재개 | H.C. Wainwright | Buy |
| 2015-06-19 | 재확인 | Brean Capital | Buy |
| 2014-12-11 | 재확인 | ROTH Capital | Buy |
| 2014-12-10 | 재확인 | ROTH Capital | Buy |
모두보기
TG테라퓨틱스사 주식(TGTX)의 최신 뉴스
Executive pay, auditor and board up for votes at TG Therapeutics (TGTX) 2026 meeting - Stock Titan
TG Therapeutics schedules Q1 results call, 2026 outlook for May 6 - Stock Titan
Pictet Asset Management Holding SA Trims Stock Position in TG Therapeutics, Inc. $TGTX - MarketBeat
Vanguard Portfolio Management discloses 5.26% stake in TG Therapeutics (NASDAQ: TGTX) - Stock Titan
TG Therapeutics Inc (TGTX) News, Articles, Events & Latest Updates - Stocktwits
TG Therapeutics Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
TG Therapeutics (TGTX) to Report Q1 Results: Wall Street Expects Earnings Growth - Yahoo Finance
TG Therapeutics secures $750M credit facility with Blue Owl, boosts buyback to $300M - MSN
TG Therapeutics, Inc. (TGTX) Stock Analysis: Unveiling a 21.71% Upside Potential in the Biotech Space - DirectorsTalk Interviews
TGTX completes enrollment in Phase III study on subcutaneous Briumvi - MSN
TG Therapeutics (TGTX) Is Up 7.6% After Advancing Subcutaneous BRIUMVI Phase 3 Trial Enrollment Completion - Sahm
TGTX Forecast, Price Target & Analyst Ratings | TG THERAPEUTICS INC (NASDAQ:TGTX) - ChartMill
(TGTX) Volatility Zones as Tactical Triggers - Stock Traders Daily
TG Therapeutics Inc. (TGTX) posts 87.3 percent year over year revenue growth despite large Q4 2025 earnings miss. - Xã Thanh Hà
Q1 EPS Estimates for TG Therapeutics Cut by HC Wainwright - MarketBeat
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting - ChartMill
TGTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
TG Therapeutics (TGTX) Slashes 18% on Lower 2025 Sales Guidance - MSN
HC Wainwright Forecasts Lower Earnings for TG Therapeutics - MarketBeat
TG Therapeutics Inc (NASDAQ:TGTX) Shows Strong Growth and Technical Setup for Potential Upside - ChartMill
TGTX Stock Price, Quote & Chart | TG THERAPEUTICS INC (NASDAQ:TGTX) - ChartMill
TG Therapeutics Stock: Flawless Execution $500M Non-Dilutive Boost Outlook (NASDAQ:TGTX) - Seeking Alpha
A Look At TG Therapeutics (TGTX) Valuation After Recent Share Price Momentum - Yahoo Finance
Has The Market Mispriced TG Therapeutics (TGTX) After Recent Biotech Sector Coverage Swings? - Sahm
Goldman Sachs Maintains TG Therapeutics(TGTX.US) With Hold Rating, Raises Target Price to $40 - Moomoo
TGTX Completes Enrollment in Phase III Study on Subcutaneous Briumvi - The Globe and Mail
TG Therapeutics concludes enrolment in Phase III Briumvi trial - Yahoo Finance
TG Therapeutics Completes Enrollment for Phase 3 Multiple Sclerosis Trial - Moomoo
TG Therapeutics (TGTX) Stock Competitive Analysis (Marginal Gain) 2026-04-15Gap Down Stocks - Xã Thanh Hà
TG Therapeutics completes enrollment in subcutaneous BRIUMVI trial By Investing.com - Investing.com Australia
TGTX Advances with Phase 3 Trial Completion for Briumvi Treatment - GuruFocus
TG Therapeutics completes enrollment in subcutaneous BRIUMVI trial - Investing.com
MS trial completion moves TG closer to at-home BRIUMVI option - Stock Titan
Update Report: Should you avoid TG Therapeutics Inc stock right now2026 Fed Impact & Weekly Return Optimization Plans - baoquankhu1.vn
Price-Driven Insight from (TGTX) for Rule-Based Strategy - Stock Traders Daily
TG Therapeutics (TGTX) reports financial results for Q4 and full year 2025 - MSN
Fed Watch: Does TG Therapeutics Inc stock benefit from AI growth2026 Trade Ideas & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Gains Recap: Is TG Therapeutics Inc a turnaround storyQuarterly Market Summary & Safe Capital Investment Plans - baoquankhu1.vn
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo! Finance Canada
BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Maintains Target Price $15 - Moomoo
Fed Meeting: Can TG Therapeutics Inc expand into new marketsMarket Trend Report & Daily Momentum Trading Reports - baoquankhu1.vn
Gains Recap: Is TG Therapeutics Inc undervalued by DCF analysis - baoquankhu1.vn
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
TGTX PE Ratio & Valuation, Is TGTX Overvalued - Intellectia AI
TG Therapeutics Inc (NASDAQ:TGTX): An Affordable Growth Stock with Strong Momentum - ChartMill
TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance UK
TG THERAPEUTICS INC (1TGTX.MI) Balance Sheet - Yahoo! Finance Canada
TG Therapeutics, Inc. (TGTX) Stock Price, News, Quote & History - Yahoo! Finance Canada
TG Therapeutics Inc. (TGTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
(TGTX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
TG Therapeutics: Briumvi Performance Aiding Upside, Buybacks Limiting Downside (TGTX) - Seeking Alpha
TG테라퓨틱스사 (TGTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
1.42%
자본화:
|
볼륨(24시간):